Catalyst Wire Dossier Catalyst Wire Dossier

GIP (glucose-dependent insulinotropic polypeptide)

glucose-dependent insulinotropic polypeptide
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GIP (glucose-dependent insulinotropic polypeptide), covering 2008-10-02 to 2008-10-02. Get the full timeline:

Most recent: Clinical Trial Update: The Beta Cell Responsiveness to Glucose-dependent Insulinotropic Polypeptide (GIP) With and Without Sulfonylurea in Patients With Type 2 Diabetes [Phase 2]

See pricing